FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 125 filers reported holding FATE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,964,000 | -81.5% | 50,000 | -73.0% | 0.87% | -80.4% |
| Q2 2021 | $16,056,000 | +5.3% | 185,000 | 0.0% | 4.41% | +23.1% |
| Q1 2021 | $15,253,000 | +1.7% | 185,000 | +12.1% | 3.58% | +7.2% |
| Q4 2020 | $15,003,000 | +87.7% | 165,000 | -17.5% | 3.34% | +44.7% |
| Q3 2020 | $7,994,000 | +86.4% | 200,000 | +60.0% | 2.31% | +104.1% |
| Q2 2020 | $4,289,000 | -14.2% | 125,000 | -44.4% | 1.13% | -14.6% |
| Q1 2020 | $4,997,000 | -7.2% | 225,000 | -18.2% | 1.32% | +29.3% |
| Q4 2019 | $5,382,000 | -1.0% | 275,000 | -21.4% | 1.02% | -26.0% |
| Q3 2019 | $5,436,000 | +344.8% | 350,000 | +366.7% | 1.38% | +432.7% |
| Q3 2018 | $1,222,000 | +156.7% | 75,000 | -15.9% | 0.26% | +21.5% |
| Q3 2015 | $476,000 | – | 89,231 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
| Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
| Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
| Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
| Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
| Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
| Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
| AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
| Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |